Cervical Endometriosis Stimulated by Estrogen Therapy Following Supracervical Hysterectomy

Shawky Z.A. Badawy, Carla Liberatore, Mohamad A. Farhat, Alfred L. Valente, Steve Landas
In: Journal of Gynecologic Surgery · 2003 · vol. 19(3) , pp. 141–144 · doi:10.1089/104240603770191087 · W2095022305
article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Histopathologic studies revealed cervical endometriosis in two patients experiencing cervical bleeding with estrogen replacement therapy after supracervical hysterectomy and bilateral salpingo-oophorectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objectives: The objective of this study is to evaluate the etiology of bleeding from the portio vaginalis of the cervix in two patients with history of severe pelvic endometriosis that required supracervical hysterectomy and bilateral salpingo-oophorectomy. These patients were on estrogen treatment postoperatively. Methods: The portiovaginalis of the cervix was excised vaginally. The specimen was submitted for histopathologic studies. Results: Histopathologic studies revealed cervical endometriosis. Conclusion: Cervical endometriosis may present as cervical bleeding with estrogen replacement therapy in patients post supracervical hysterectomy.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Cited by (4)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK